Week 1: Antiarrhythmic drugs Flashcards

1
Q

What is the difference between pacemaker potentials and non pacemaker potentials?

A

Pacemaker potentials are slow- no true resting membrane potential, but influx via If “funny” currents, mixed Na+/K+ current, that slowly depolarises cell to threshold (phase 4) , opening of T type (transient Ca2+ ), depolarisation then by L type Ca2+ channel, repolarisation by K+ channels.

Cardiac AP - specific resting Vm (-90mv), AP arrives, opening Na+ channels, fast depol by Na+, transient repol by K+ current, then plateau by influx Ca2+ through L type Ca channels, then Na+ and Ca2+ channels close, repolarisation by K+ outflow.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the mechanisms of cardiac arrhythmias?

What are some common causes of cardiac arrhythmias?

A

Result from disorder of impulse formation, conduction or both.

Causes:

Cardiac ischaemia

Excessive discharge or sensitivity to autonomic transmitters

exposure to toxic substances

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are the classes of arrythmic mechanisms?

A

Automaticity:

  • Enhanced
  • Abnormal

Triggered activity:

  • Early afterdepolarisation
  • Delayed afterdepolarisation

Re-entry

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Pathophysiology of enhanced automaticity?

Pathophysiology of abnormal automaticity?

A

Enhanced cardiac automaticity refers to the accelerated generation of an action potential by either normal pacemaker tissue (enhanced normal automaticity) or by abnormal tissue in mycardium (abnormal automaticity).

Enhanced normal automaticity –> accounts for sinus tachycardia

Abnormal automaticity –> results in atrial or ventricular arrhythmias

Under normal circumstances the SA node is responsible for the generation of AP’s in the heart, and is the primary pacemaker. This automaticity increases during exercise - normal physiological increase in automaticity. In other circumstances the automaticity in SA and other latent pacemakers can increase without physiological motivation –> E.g. ischaemia during MI increasing automaticity in purkinje cells. Under pathological circumstances, atrial and ventricular myocardium (does not posses normal automaticity) can start discharging AP’s –> abnormal automaticity. Can cause extra beats.

Other conditions that induce abnormal automaticity –> MI/hypoxia/ Hypokalaemia/ lung disease/ digoxin (alter resting membrane of the cell bringing it closer to threshold for depolarisation).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Pathophysiology of triggered activity?

A

AP may induce an after depolarisation –> is a depolarisation occurring either during or after the repolarisation phase. After depolarisation occuring during repolarisation = early depolarisation. After depolarisation occurring after repolarisaton = late depolarisation.

Early and late depolarisation may be strong enough to reach threshold for eliciting another AP –> this is triggered activitiy

EAD -> typically in bradycardia, hypokalaemia, hypoxia, acidosis, hypocalcaemia, drug SE.

DAD –> digoxin overdose and SNS stimulation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Pathophysiology of re-entry?

A

For re-entry to occur you need 1) a unidirectional block within a conducting pathway 2) critical timing -> in that the AP travelling down one conducting pathway can come back on itself as it finds tissue that is re-excitable. This is related to the effective refractory period of this tissue.

AP travels down one branch of excitable tissue in the conducting pathway, but cannot travel down the other due to conduction block (e.g. scar tissue),it can then travel retrograde up this pathway and re-enter the circuit –> circular pathway of high freq impulses (tachyarrhythmia).

This can happen locally i.e within atria (e.g. AV nodal re-entry or AV re-entrant tachycardia) or globally, i.e between atria and ventricles. E.g. in WPW syndrome accessory pathway (bundle of kent) exists which allows AP to travel from atria to ventricles and back up the AV node back into the atria –> SVT.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are the principles of cardiac pharmacotherapy?

A
  • Change heart rate
  • Increase force of cardiac muscle contraction
  • Alter depolarisaton/repolarisation of the myocardium
  • Change the flow through the coronary arteries
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are the components of heart rate control?

A

Intrinsic pacemaker - SAN, if that fails AVN takes over, if that fails escape rhythm (but at slower rate) from other tissues in conducting pathway.

Autonomic nervous system:

SNS - NA is the accelerator of the heart, therefore blocking this accelerator slows the heart. NA released post synaptically onto beta adrenergic receptors in SAN/ AVN.

PNS –> the vagus nerve is the “handbrake” of the heart, therefore blocking Ach at the muscarinic receptors releases this handbreak.

Receptors - as above.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the mechanism of action of atropine?

What is the indiction?

How is it administered?

What are the SE’s?

A

Atropine

MOA–> blocks the muscarinic receptors in the SA and AVN. By blocking the PNS stimulation it allows the heart to beat faster

Indication – > emergency treatment of bradycardia

Administration –> IV bolus

SE’s –> due to other Ach receptors in the body:

  • Dry mouth
  • urinary retention
  • dilated pupils
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is the MOA of Beta blockers?

Drug names?

Indication in arrhythmia

SE?

Contraindications?

A

Beta blockers:

MOA: Blocks the increase in the slope of phase 4 depolarisation in the pacemaker cells of the heart by blocking the B1 adrenergic receptors. NA cannot bind in SAN and AVN, slowing the heart rate.

Drug names: Atenolol, metoprolol, carvedilolol, bisoprolol

Indication in arrhythmia: Cardi protective drugs, rate control in atrial flutter and fibrillation. Also effectiv in ventricular arrhythmia related to SNS activation e.g. ACS, heart failure.

SE: bronchospasm, bradycardia, headache, sleep disturbance, increase insulin resistance. High degree AV block = complete contraindication. Asthma = relative contraindication, if in COPD start slow and low.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Which drugs are used to alter HR?

What is their MoA?

A
  • Beta blockers
    • Blocks B1 receptors in the SA and AV nodes, blocking sympathetic input to reduce HR
  • Atropine
    • Blocks Ach recceptors in SA and AV nodes, blocking parasympathetic input to increase HR
  • If channel blockers
    • Selective If blocker- works only in SA node
    • Slows Na+ entry, slower pacemaker potential
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Which drugs are used to increase the force of contraction of cardiac muscle?

A
  • Cardiac glycoside (usually digoxin)
  • Negative inotropes (usually reduce force of contraction as a side effect)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are the If channel blockers?

what is this drug called?

MOA?

A

If blockers - block the “funny channel” –> the mixed Na+/K+ channel that is responsible for the slow depoalarising waves of the pacemaker potential

Drug name: Ivabradine

Slows the Na+ entry, slowing pacemaker potential, acts only in the SA node.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is the action of a cardiac glycoside?

What is the usual agent?

What is its MOA?

A

Cardiac glycoside - class of drug that increases the force of contraction but decreases the rate of contractions in the heart (negative chronotrope).

Usual agent: Digoxin

MOA: Acts on Na/K+ ATPase pump. Normally moves K+ ions in and Na+ ions out, cardiac glycosides inhibit the pump so that Na+ cannot be extruded, intracellular Na+ therefore increases.

Raised IC Na+ inhibits the function of second membrane exchanger - NCX. Normally passively exchanges Ca+ out and Na+ ions in, and is reliant upon the concentration gradient of Na+ –> therefore Ca+ ion not extruded and also builds up in the cell. –> Increased force of contraction of myocytes.

Refractory period of AV node also increased, therefore cardiac glycosides reduce the heart rate.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What drugs affect the force of contraction by negative inotropy as a side effect?

A

Usually dont want to reduce the force of contraction but reduced contraction force may be a side effect of:

Beta blockers –> block adrenergic receptors / affect of adrenaline and therefore reduce IC Ca2+ conc –> therefore reduce force of contraction

Ca2+ antagonists - e.g. verapamil –> inhibit L type Ca2+ channels, reduce IC Ca2+ and therefore reduce the force of contraction.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

How do beta blockers reduce force of contraction as a side effect?

A

Block adrenergic receptors, blocking the effect of adrenaline.

Reduced iCa2+ therefore reduced force of contraction

17
Q

How do Ca2+ antagonists reduce force of contraction as a side effect?

A

Inhibit L-type Ca2+ channels, decreased iCa2+ , therefore reducing force of contraction

18
Q

Which drugs are used to alter depolarisation/repolarisation of the myocardium?

What are their classes?

A

Quinidine: Class 1a

Lidocaine: Class 1b

Flecainide: Class 1c

Amiodarone: Class III

Verapamil: Class IV

19
Q

What drugs affect depolarisation and repolarisation?

How can they reduce arrhythmia?

A

Lignocaine, propafenone, flecainide

All block ion channels involved in the action potential

Some affect the action potential by prolonging it

The myocardium remains refractory for longer

therefore is less likely to propagate the arrhythmia

Often can reduce myocardial function –> myocardial depressant

20
Q

What are the phases of the cardiac action potential?

A

Phase 0 - fast depolarisation due to Na+ entry

Phase 1- transient replarisation by K+ movement out

Phase 2 - plateau phase by calcium entry and K+ out

Phase 3- repolarisation by K+ movement out

Phase 4- resting membrane potential (-90mv) achieved by Na+ movement out, K+ in

21
Q

What is the Vaughnan williams classification of antiarrhythmics?

What are the different classes?

What channel do they act on/ overall MOA?

What are some examples of each class?

A

Classification system for the classes of antiarrhythmic drugs: Class 1 - 4, Class 1 split into three subclasses (1A/1B/1C).

Class 1 - sodium channel blockers, reduce phase 0 slope and the peak of action potential. Class 1a - moderate, class 1b - weak, class 1c - strong.

  • Class 1a: disopyramide: quinidine
  • Class 1b: lidocaine
  • Class 1c: flecainide propafenone

Class 2 - Beta Blockers –> Block SNS activity, reduce rate and conduction. Examples: Atenolol, bisprolol, metoprolol.

Class 3 - K+ channel blocker –> Delay repolarisation, therefore increase AP duration and ERP. Examples: Amiodarone, dronedarone, sotolol (some beta blocker activity)

Class 4 - Ca2+ channel blocker –> Block L type Ca2+ channel, most effect at SA/AVN, reduce rate and conduction. Examples: Verapamil, Diltiazem

22
Q

What are the class 1a drugs?

What are their MOA?

What are its uses?

SE?

A

Class 1a: Quinidine and Disopyramide

Moderate Fast Na+ channel block, moderate reduction in phase 0 slope (delay depolarisation in fast Na+ channels), increase AP duration, increase ERP

Uses/ indication: Ventricular and supraventricular arrhythmias

SE: odema

23
Q

What are the class 1b drugs?

What is the MOA?

uses/ indication?

SE?

A

Class Ib - Lidocaine

Weak Na+ channel block, blocking Na+ channels in actively depolarising cells/depolarising areas. Reduce the APD, decrease ERP.

Also a local anaesthetic, short duration of action (milliseconds) on the Na+ channel, greatest effect on rapidly beating/ depolarising cells. Thus rapidly beating cells are blocked from depolarising. Less effect on normally beating cells.

Uses/indication: CPR - when lidocaine used IV.

SE: Oedema

24
Q

What are the class IC drugs?

MOA?

Uses?

SE?

A

Class Ic - Flecainide, Propafenone.

MOA: Strong effect on depolarisation, pronounced reduction in phase 0 slope (depolarisation). No effect on APD or ERP.

Uses/ Indication: Paroxysmal AF and ventricular ectopic beats “pill in pocket”.

SE: Odema

25
Q

What are the class III antiarrhythmic drugs?

A

Class III –> K+ channel blockers

Amiodarone, Dronedarone, sotolol (some beta blocker activity).

Delay repolarisation –> prolong AP duration and ERP (prolong QT interval)

Uses: Supraventricular, nodal and ventricular arrhythmias, atrial fibrillation (CPR used IV)

SE: N&V

26
Q

What are the class 4 antiarrythmic drugs?

MOA?

Uses?

SE?

A

Class 4: Verapamil and diltiazem

MOA: Ca2+ channel blocker (L-type), reduces amplitude and shortens phase 2 plateau phase.

Reduces IC Ca2+, therefore -ve inotropic effects on myocytes. Most effective at SA and AVN (reduce phase 0 depolarisation by slow ca2+ influx) therefore reduce chronotropy and inotropy, Reduce CO.

Uses: supraventricular tachycardia - e.g atrial fibrillation and atrial flutter. Slows conduction to the ventricles by L type Ca2+ block (block the depolarisation of the Pacemaker potential too, phase 0 Ca2+ influx.)

SE: Hypotension with verapamil, constipation with diltiazem.

27
Q

What is the mechanims of action of adenosine?

What is it used for?

What is the half life?

A

Binds A1 receptor in pacemaker tissue, inhibits adenylyl cyclase, reduces cAMP; K+ efflux increases and cells are transiently hyperpolarised.

Used IV to diagnose and treat AV node dependent tachycardias.

It has a short half life of seconds.

28
Q

Calcium channel blockers: describe the mechanism of action of non-dihydropyridines.

Name 2 drugs from this class

A

Verapamil and diltiazem (class IV)

Work on the myocardium and arterioles:

  • Anti-arrhythmic by AV node block
  • Anti-angina (similar to B blockers - reduce workload of heart, reduced O2 demand)
  • Anti HTN by arteriolar relaxation
29
Q

What are the dihydropyridine Ca2+ channel blockers?

A

Dihydropyridines: Nifedipine and amlodipine

MOA: Block Ca2+ channels in the SMC’s surrounding arterioles –> predominantly very effective for HTN.

30
Q

What is the MOA of magnesium?

What is the inidication?

What is the dose and administration method?

A

Magnesium has an unknown MOA –> influence Na/K+ ATPase, Na+ channels, K+ channels and Ca2+ channels.

Uses: Emergency arrhythmia treatment, in a variety of arrythmia to stabilise AP’s –> Torsade de pointes or refractory VT’s is therapy of choice

Dose: 1-2g over 20 minutes (even if Mg level is normal)

SE: Can cause electrolyte abnormalities.